Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 6

Vaccination against hepatitis A in children: A review of the evidence

Authors Paolo Bonanni, Sara Boccalini, Angela Bechini

Published 15 January 2008 Volume 2007:3(6) Pages 1071—1076

Paolo Bonanni, Sara Boccalini, Angela Bechini
Department of Public Health, University of Florence, Florence, Italy
Abstract: Safe and effective vaccines against hepatitis A have now been available on the market for almost 15 years. This review focuses on the evidence of the effect of such vaccination in children when applied both within routine immunization programs and in groups at high risk of infection, but also as a measure to stop limited or community-wide outbreaks.
Keywords: hepatitis A, vaccination, epidemiology, outbreaks, effectiveness, herd immunity

Download Article [PDF] 

Readers of this article also read:

Early ischemic CT changes before thrombolysis: The influence of age and diabetes mellitus

Lars Thomassen, Ulrike Waje-Andreassen, Halvor Naess

Therapeutics and Clinical Risk Management 2008, 4:699-703

Published Date: 8 August 2008

An “acquired” hemoglobin J variant in a sickle cell disease patient

Nawwar Swedan, Kathleen Nicol, Phylis Moder, Samir Kahwash

Therapeutics and Clinical Risk Management 2008, 4:649-652

Published Date: 6 June 2008

Treatment of non-alcoholic fatty liver disease

Keith G Tolman, Anthony S Dalpiaz

Therapeutics and Clinical Risk Management 2007, 3:1153-1163

Published Date: 15 January 2008

Satraplatin in the treatment of hormone-refractory metastatic prostate cancer

Andrew J Armstrong, Daniel J George

Therapeutics and Clinical Risk Management 2007, 3:877-883

Published Date: 15 November 2007

A review of anti-IgE monoclonal antibody (omalizumab) as add on therapy for severe allergic (IgE-mediated) asthma

Gennaro D’Amato, Antonello Salzillo. Amedeo Piccolo, Maria D’Amato, Gennaro Liccardi

Therapeutics and Clinical Risk Management 2007, 3:613-619

Published Date: 15 September 2007

Bortezomib (Velcade™) in the treatment of multiple myeloma

Antonia Field-Smith, Gareth J Morgan, Faith E Davies

Therapeutics and Clinical Risk Management 2006, 2:271-279

Published Date: 15 September 2006